ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01186861
Brief Title: Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy

First Submitted : August 19, 2010
First Submitted that Met QC Criteria : August 19, 2010
First Posted : August 23, 2010 (Estimate)

Certification/Extension First Submitted : June 19, 2014
Certification/Extension First Submitted that Met QC Criteria : June 19, 2014
Certification/Extension First Posted : June 23, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 7, 2015
Last Update Posted : April 29, 2015 (Estimate)